Wellington Shields & Co., LLC Bristol Myers Squibb CO Transaction History

Wellington Shields & Co., LLC

$296 Million
Q1 2024

A detailed history of Wellington Shields & Co., LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 35,233 shares of BMY stock, worth $1.46 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

35,233

Previous 36,983 4.73%

Holding current value

$1.46 Million

Previous $1.9 Million 0.69%

% of portfolio

0.65%

Previous 0.7%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 23, 2024	SELL	$47.98 - $54.4 $83,965 - $95,200	-1,750 Reduced 4.73%	35,233 $1.91 Million
Q1 2024 May 23, 2024	BUY	$47.98 - $54.4 $83,965 - $95,200	1,750 Added 4.97%	36,983 $2.01 Million
Q1 2024 May 03, 2024	SELL	$47.98 - $54.4 $85,884 - $97,376	-1,790 Reduced 4.83%	35,233 $1.91 Million
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $26,373 - $31,470	544 Added 1.49%	37,023 $1.9 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $810 - $906	14 Added 0.04%	36,479 $2.12 Million

Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $95,565 - $106,109	-1,500 Reduced 3.95%	36,465 $2.33 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $19,712 - $22,359	300 Added 0.8%	37,965 $2.63 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $29,104 - $34,463	425 Added 1.14%	37,665 $2.71 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $3 - $1,921	25 Added 0.07%	37,240 $2.65 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $580,960 - $639,840	-8,000 Reduced 17.69%	37,215 $2.87 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $92,220 - $110,580	1,500 Added 3.43%	45,215 $3.3 Million
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $295,501 - $344,485	-5,510 Reduced 11.19%	43,715 $2.73 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $89,346 - $104,658	1,510 Added 3.16%	49,225 $2.91 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $68,101 - $74,162	-1,100 Reduced 2.25%	47,715 $3.19 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $154,284 - $173,524	-2,600 Reduced 5.06%	48,815 $3.08 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $40,418 - $45,801	-700 Reduced 1.34%	51,415 $3.19 Million
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $28,715 - $31,820	500 Added 0.97%	52,115 $3.14 Million
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $22,750 - $26,597	415 Added 0.81%	51,615 $3.04 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $28,304 - $41,132	-610 Reduced 1.18%	51,200 $2.85 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $2.55 Million - $3.33 Million	51,810 New	51,810 $3.33 Million
Q3 2019 Nov 05, 2019	SELL	$42.77 - $50.71 $1.85 Million - $2.2 Million	-43,350 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$44.62 - $49.34 $8,924 - $9,868	-200 Reduced 0.46%	43,350 $1.97 Million
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $182,736 - $217,890	-4,050 Reduced 8.51%	43,550 $2.08 Million
Q4 2018 Feb 11, 2019	BUY	$48.76 - $63.23 $173,098 - $224,466	3,550 Added 8.06%	47,600 $2.47 Million
Q3 2018 Nov 06, 2018	SELL	$55.19 - $62.25 $11,038 - $12,450	-200 Reduced 0.45%	44,050 $2.74 Million
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $30,318 - $37,788	-600 Reduced 1.34%	44,250 $2.45 Million
Q1 2018 May 03, 2018	BUY	$59.92 - $68.98 $5,992 - $6,898	100 Added 0.22%	44,850 $0
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $105,134 - $114,623	-1,754 Reduced 3.77%	44,750 $2.74 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $2.57 Million - $2.96 Million	46,504	46,504 $0

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.

Account

Wellington Shields & Co., LLC Bristol Myers Squibb CO Transaction History